文献速递细菌感染、耐药与抗菌药物医院感染防控

2005-2014年侵袭性耐甲氧西林金黄色葡萄球菌感染的种族差异

Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014.
PubMed 文献 · Clin Infect Dis · 2018-01-01

基于美国9个州2005-2014年 Emerging Infections Program 监测数据,分析侵袭性MRSA发病率下降是否影响种族差异。结果显示医院发病和医疗保健相关社区发病MRSA率下降,但黑人患者三类MRSA率均持续高于白人,且差异未随时间改变。

要点

  • 2005-2014年医院发病和医疗保健相关社区发病侵袭性MRSA率下降,社区相关MRSA率未下降。
  • 黑人患者医院发病MRSA调整率比为3.20(95%CI 2.35-4.35),高于白人患者。
  • 黑人患者医疗保健相关社区发病MRSA调整率比为3.84(95%CI 2.94-5.01),高于白人患者。

核心结论

  • 既往医疗保健相关MRSA感染的下降未影响MRSA发病率的种族差异。
  • 需要更好地理解这些差异的潜在原因,以制定减少MRSA感染种族差异的有效预防干预措施。

研究设计与样本

  • 分析美国9个州 Emerging Infections Program 2005-2014年监测数据。
  • 病例分类包括医院发病(入院后培养>3天)、医疗保健相关社区发病(入院后培养≤3天且既往1年内有透析、住院、手术或长期护理机构居住)或社区相关(其他所有)。
  • 采用负二项回归模型评估黑人患者相对于白人患者的调整率比(aRR),控制年龄、性别和时间趋势。

主要发现

  • 2005-2014年侵袭性医院发病和医疗保健相关社区发病MRSA率下降,社区相关MRSA率未下降。
  • 黑人患者医院发病MRSA调整率比为3.20(95%CI 2.35-4.35),高于白人患者。
  • 黑人患者医疗保健相关社区发病MRSA调整率比为3.84(95%CI 2.94-5.01),高于白人患者。
  • 黑人患者社区相关MRSA调整率比为2.78(95%CI 2.30-3.37),高于白人患者。
  • 限定于慢性透析患者分析后,黑人患者医疗保健相关社区发病MRSA调整率比为1.83(95%CI 1.72-1.96),仍高于白人患者;尽管2005-2014年透析患者侵袭性MRSA率下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite substantial attention to the individual topics, little is known about the relationship between racial disparities and antimicrobial-resistant and/or healthcare-associated infection trends, such as for methicillin-resistant Staphylococcus aureus (MRSA). METHODS: We analyzed Emerging Infections Program 2005-2014 surveillance data (9 US states) to determine whether reductions in invasive MRSA incidence (isolated from normally sterile body sites) affected racial disparities in rates. Case classification included hospital-onset (HO, culture >3 days after admission), healthcare-associated community onset (HACO, culture ≤3 days after admission and dialysis, hospitalization, surgery, or long-term care residence within 1 year prior), or community-associated (CA, all others). Negative binomial regression models were used to evaluate the adjusted rate ratio (aRR) of MRSA in black patients (vs in white patients) controlling for age, sex, and temporal trends. RESULTS: During 2005-2014, invasive HO and HACO (but not CA) MRSA rates decreased. Despite this, blacks had higher rates for HO (aRR, 3.20; 95% confidence interval [CI], 2.35-4.35), HACO (aRR, 3.84; 95% CI, 2.94-5.01), and CA (aRR, 2.78; 95% CI, 2.30-3.37) MRSA. Limiting the analysis to chronic dialysis patients reduced, but did not eliminate, the higher HACO MRSA rates among blacks (aRR, 1.83; 95% CI, 1.72-1.96), even though invasive MRSA rates among dialysis patients decreased during 2005-2014. These racial differences did not change over time. CONCLUSIONS: Previous reductions in healthcare-associated MRSA infections have not affected racial disparities in MRSA rates. Improved understanding of the underlying causes of these differences is needed to develop effective prevention interventions that reduce racial disparities in MRSA infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gualandi N, Mu Y, Bamberg WM, et al. Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014. Clin Infect Dis. 2018. PMID: 29659728. doi:10.1093/cid/ciy277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。